Our findings suggest that IL-6 serves as a cell-extrinsic factor secreted by cancer cells in response to genotoxic treatments (Figs. 1E, F and S1E) to counteract the anti-survival and -metastatic activities of these anticancer agents. Here, IL6 is linked to cancer.